Charles Schwab Investment Management Inc Rocket Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 532,563 shares of RCKT stock, worth $10.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
532,563
Previous 525,452
1.35%
Holding current value
$10.5 Million
Previous $15.7 Million
8.89%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding RCKT
# of Institutions
204Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$350 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$181 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$106 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$82.9 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.5B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...